Pharmaceutical Articles, Insights & Blogs

Duchenne Muscular Dystrophy Treatment: Approved Medicines and How to Source Them

Lyme Disease in Dogs: Prevention, Treatment, and How to Source the Right Medicines

What Are Biosimilar Drugs? Development & Applications

Named Patient Program vs Compassionate Use Program: Understanding the Key Differences

Are Branded medicines really the same across markets

Audit Visit invitation

Courier Mode vs Air Cargo Mode

Driving Compliant Early Access through GNH GAPMAP

Elizaria Named Patient Programme Feasibility Assessment or India

Emergency and Special Access Pathways for Pharmaceuticals

Expanded Access Programmes GAP Strategic Initiative

Expanding Global Access to Wockhardts Breakthrough Antibiotic Zaynich

Faster Access Isnt a Luxury Its a Necessity

GAP and NPP Initiatives GNH USA Overview

GAP and NPP Initiatives Real World Execution by GNH USA

Global Access Platform One System for Reference Drugs Emergencies and Shortages

Global and Managed Access Programs

Global Continuity Partner

Global Leader Local Partner

GNH Early Access Programme Operating Model for Nivolumab Biosimilar

GNH India Expanded Access Program EAP Execution Capabilities

GNHs 2026 Vision Quantum Speed 100x Productivity Patient First

Import and Export of Pharmaceutical Medicines

Import of Pharmaceutical Medicines

Incorporating Real World Data into Named Patient Programmes

India Market Entry Strategy Elizaria Generium

Navigating Indias Evolving Pharmaceutical Regulatory Landscape

NPP access Cross Border Biologics legal view

NPP access The Legal Bridge

NPP in Action Live Case Examples from GNH USA

Optimized Vendor Qualification

Pharma Business Development Operating System

Pharmaceutical Import and Export Logistics

Pharmaceutical Import Logistics Mode Selection Guide

Regulatory Grade RLD and Comparator Sourcing

RLD and Comparator Sourcing

RLD Emergency supply for Russia

Strategic Services GNH India Can Provide to Remedex

The Role of Indian Pharmaceutical Exporters in Global Healthcare

How Pharmaceutical Manufacturers Ensure Quality and Safety

The Importance of Stability Programs in Early Clinical Drug Product Development

Transforming Clinical Trial Supply Chain Optimization Through Digitalization

Named Patient Supply: A Lifeline for Patients Needing Unavailable Medicines

Understanding Regulatory Challenges in Global Pharmaceutical Exports

How GNH India Supports Clinical Trials Through Reliable Drug Supply Chains

Cold Chain Logistics in Pharmaceuticals: Ensuring Potency from Factory to Patient

Articles & Blogs